| Microbial genomes from non-human primate gut metagenomes expand the primate-associated bacterial tree of life with over 1000 novel species S Manara, F Asnicar, F Beghini, D Bazzani, F Cumbo, M Zolfo, E Nigro, ... Genome biology 20, 1-16, 2019 | 69 | 2019 |
| Cultivation-independent genomes greatly expand taxonomic-profiling capabilities of mOTUs across various environments HJ Ruscheweyh, A Milanese, L Paoli, N Karcher, Q Clayssen, MI Keller, ... Microbiome 10 (1), 212, 2022 | 64 | 2022 |
| Enterotypes of the human gut mycobiome S Lai, Y Yan, Y Pu, S Lin, JG Qiu, BH Jiang, MI Keller, M Wang, P Bork, ... Microbiome 11 (1), 179, 2023 | 36 | 2023 |
| Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases M Thiele, IF Villesen, L Niu, S Johansen, K Sulek, S Nishijima, ... Journal of Hepatology, 2024 | 10 | 2024 |
| A volatile and dynamic longitudinal microbiome is associated with less reduction in lung function in adolescents with cystic fibrosis MI Metzger, SY Graeber, M Stahl, O Sommerburg, MA Mall, AH Dalpke, ... Frontiers in Cellular and Infection Microbiology 11, 763121, 2021 | 10 | 2021 |
| Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations S Nishijima, E Stankevic, O Aasmets, TSB Schmidt, N Nagata, MI Keller, ... Cell 188 (1), 222-236. e15, 2025 | 8 | 2025 |
| Terlipressin therapy is associated with increased risk of colonisation with multidrug‐resistant bacteria in patients with decompensated cirrhosis MM Mücke, M Hernández‐Tejero, W Gu, M Kuhn, M Janz, MI Keller, ... Alimentary Pharmacology & Therapeutics 59 (7), 877-888, 2024 | 5 | 2024 |
| Refined Enterotyping reveals dysbiosis in global fecal metagenomes MI Keller, S Nishijima, D Podlesny, CY Kim, SM Robbani, C Schudoma, ... bioRxiv, 2024.08. 13.607711, 2024 | 4 | 2024 |
| OS-071-YI Variation of the human microbiome across multiple body sites and temporal dynamics in different stages of decompensated cirrhosis W Gu, A Broekhoven, S Van Blerk, MI Keller, M Kuhn, A Roulet, ... Journal of Hepatology 80, S47, 2024 | | 2024 |
| TOP-563 Phages targeting Enterococcus B bacteria associated with increased short-term mortality and proven bacterial infection in patients with decompensated liver cirrhosis … L Van Espen, L Close, R Schierwagen, W Gu, MI Keller, A Fullam, M Kuhn, ... Journal of Hepatology 80, S272, 2024 | | 2024 |
| FRI-039 Terlipressin therapy is associated with increased risk of colonization with multidrug-resistant bacteria in patients with decompensated cirrhosis M Mucke, M Hernandez-Tejero, W Gu, M Kuhn, M Janz, MI Keller, ... Journal of Hepatology 80, S203, 2024 | | 2024 |
| OS-073 Linking gut microbiome enterotypes and dysbiosis to liver disease severity and prognosis MI Keller, S Nishijima, D Podlesny, CY Kim, SM Robbani, C Schudoma, ... Journal of Hepatology 80, S48, 2024 | | 2024 |
| Identifying patterns of steatotic liver disease severity: a multi-omic analysis of 834 distinct omics features from healthy to end-stage liver disease in 854 individuals JK Hansen, S Nishijima, R Schierwagen, LA Holm, K Sulek, T Suvitaival, ... Journal of Hepatology 80, 2024 | | 2024 |
| An oat drink fermented by lactobacillus plantarum reduces formation of liver fibrosis via beneficial effects on the gut microbiome and circulating bile acids in patients with … JK Hansen, C Hansen, M Israelsen, S Nishijima, P Andersen, K Sulek, ... Hepatology 78 (Suppl. 1), 3519-C, 2023 | | 2023 |
| mOTUs3: An updated tool for microbiome profiling of diverse samples without reference genomes HJ Ruscheweyh, A Milanese, L Paoli, N Karcher, Q Clayssen, MI Keller, ... | | 2023 |
| Einfluss einer Terlipressin-Therapie auf das Risiko für eine Kolonisation mit multiresistenten Erregern bei Patienten mit dekompensierter Leberzirrhose MM Mücke, M Hernádez-Tejero, W Gu, M Kuhn, M Janz, MI Keller, ... Zeitschrift für Gastroenterologie 61 (08), KV155, 2023 | | 2023 |
| Enterotypes of the human gut mycobiome YY Senying Lai, Y Pu, S Lin, JG Qiu, BH Jiang, MI Keller, M Wang, P Bork, ... | | 2023 |
